Pulsenmore Ltd. announced that the Israel Innovation Authority approved a $1.27 million grant for its SmartScan AI research and development program on August 17, 2026. This funding supports a 12-month initiative to develop AI-powered real-time ultrasound analysis and dynamic guidance to reduce operator dependency in home scans. The approval marks the second AI grant received within one month, bringing total recent support to approximately $1.6 million for programs with a combined scope of $3.12 million. Pulsenmore operates in the medical technology industry, specializing in home-use ultrasound devices for maternal health.
